262 related articles for article (PubMed ID: 3442182)
21. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus.
Horowitz M; Maddox A; Harding PE; Maddern GJ; Chatterton BE; Wishart J; Shearman DJ
Gastroenterology; 1987 Jun; 92(6):1899-907. PubMed ID: 3569766
[TBL] [Abstract][Full Text] [Related]
22. Effects of mosapride citrate, metoclopramide hydrochloride, lidocaine hydrochloride, and cisapride citrate on equine gastric emptying, small intestinal and caecal motility.
Okamura K; Sasaki N; Yamada M; Yamada H; Inokuma H
Res Vet Sci; 2009 Apr; 86(2):302-8. PubMed ID: 18723200
[TBL] [Abstract][Full Text] [Related]
23. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa.
Stacher G; Bergmann H; Wiesnagrotzki S; Kiss A; Schneider C; Mittelbach G; Gaupmann G; Höbart J
Gastroenterology; 1987 Apr; 92(4):1000-6. PubMed ID: 3556983
[TBL] [Abstract][Full Text] [Related]
24. Cisapride vs metoclopramide. An acute study in diabetic gastroparesis.
McHugh S; Lico S; Diamant NE
Dig Dis Sci; 1992 Jul; 37(7):997-1001. PubMed ID: 1618070
[TBL] [Abstract][Full Text] [Related]
25. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients.
McCallum RW; Fink SM; Lerner E; Berkowitz DM
Gastroenterology; 1983 Jun; 84(6):1573-7. PubMed ID: 6132852
[TBL] [Abstract][Full Text] [Related]
26. The mycotoxin, deoxynivalenol, delays gastric emptying through serotonin-3 receptors in rodents.
Fioramonti J; Dupuy C; Dupuy J; Bueno L
J Pharmacol Exp Ther; 1993 Sep; 266(3):1255-60. PubMed ID: 8371135
[TBL] [Abstract][Full Text] [Related]
27. Metoclopramide-induced gastric emptying in patients with anorexia nervosa.
Saleh JW; Lebwohl P
Am J Gastroenterol; 1980 Aug; 74(2):127-32. PubMed ID: 7446514
[TBL] [Abstract][Full Text] [Related]
28. Effect of cisapride on response fluctuations in Parkinson's disease.
Djaldetti R; Koren M; Ziv I; Achiron A; Melamed E
Mov Disord; 1995 Jan; 10(1):81-4. PubMed ID: 7885359
[TBL] [Abstract][Full Text] [Related]
29. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
Megens AA; Awouters FH; Niemegeers CJ
Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride.
Borovicka J; Lehmann R; Kunz P; Fraser R; Kreiss C; Crelier G; Boesiger P; Spinas GA; Fried M; Schwizer W
Am J Gastroenterol; 1999 Oct; 94(10):2866-73. PubMed ID: 10520835
[TBL] [Abstract][Full Text] [Related]
31. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
[TBL] [Abstract][Full Text] [Related]
32. Cisapride offsets dopamine-induced slowing of fasting gastric emptying.
Müller-Lissner SA; Fraas C; Härtl A
Dig Dis Sci; 1986 Aug; 31(8):807-10. PubMed ID: 3731974
[TBL] [Abstract][Full Text] [Related]
33. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study.
Esfandyari T; Camilleri M; Ferber I; Burton D; Baxter K; Zinsmeister AR
Neurogastroenterol Motil; 2006 Sep; 18(9):831-8. PubMed ID: 16918762
[TBL] [Abstract][Full Text] [Related]
34. Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).
Jian R; Ducrot F; Piedeloup C; Mary JY; Najean Y; Bernier JJ
Gut; 1985 Apr; 26(4):352-8. PubMed ID: 3884468
[TBL] [Abstract][Full Text] [Related]
35. Single oral dose of cisapride accelerates gastric antral emptying in healthy humans: an ultrasonographic study.
Takeda T; Konomi H; Naritomi G; Yoshida J; Matsunaga H; Akazawa K; Tanaka M
J Gastroenterol; 1996 Jun; 31(3):323-8. PubMed ID: 8726821
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and tolerability of cisapride in a new formula of 10 mg effervescent capsules for the treatment of functional dyspepsia].
Grossi L; Di Felice F; Marzio L
Clin Ter; 1993 Jun; 142(6):521-7. PubMed ID: 8354045
[TBL] [Abstract][Full Text] [Related]
37. A foreshortened method of measuring liquid gastric emptying in normal volunteers.
van Wyk M; Sommers DK; Snyman JR; Moncrieff J
Methods Find Exp Clin Pharmacol; 1993; 15(1):61-6. PubMed ID: 8479248
[TBL] [Abstract][Full Text] [Related]
38. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
[TBL] [Abstract][Full Text] [Related]
39. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
Deruyttere M; Lepoutre L; Heylen H; Samain H; Pennoit H
Clin Ther; 1987; 10(1):44-51. PubMed ID: 3329964
[TBL] [Abstract][Full Text] [Related]
40. [The evaluation of the time of gastric radio-isotopic emptying in subjects with non-insulin dependent diabetes mellitus].
Allegra G; Costa R; Scaffidi L; Campisi D; Cangialosi G; Scaffidi A
Clin Ter; 1996 Mar; 147(3):93-8. PubMed ID: 8767974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
